Literature DB >> 21622538

Oral artesunate-amodiaquine and artemether-lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children.

Grace O Gbotosho1, Akintunde Sowunmi, Titilope M Okuboyejo, Christian T Happi.   

Abstract

The therapeutic efficacy, changes in haematocrit and declines in parasitaemias were evaluated in 56 children with uncomplicated falciparum hyperparasitaemia after oral artesunate-amodiaquine or artemether-lumefantrine. All children recovered clinically within 2 days and without progression to severe malaria. Falls in haematocrit in the first 3 days after treatment began were similar and <5%. Declines in parasitaemias were monoexponential with both treatments with an estimated half-life of 1 h.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622538     DOI: 10.1093/tropej/fmr045

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  3 in total

1.  It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis.

Authors:  B M Gruessner; L Cornet-Vernet; M R Desrosiers; P Lutgen; M J Towler; P J Weathers
Journal:  Phytochem Rev       Date:  2019-09-19       Impact factor: 5.374

2.  Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.

Authors:  Serge-Brice Assi; Yapo Thomas Aba; Jean Claude Yavo; Abouo Franklin Nguessan; N'cho Bertin Tchiekoi; Koffi Moïse San; Emmanuel Bissagnéné; Stephan Duparc; Valérie Lameyre; Mea Antoine Tanoh
Journal:  Malar J       Date:  2017-01-03       Impact factor: 2.979

3.  Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Godwin Ntadom; Temitope Aderoyeje; Elsie O Adewoye; Bayo Fatunmbi
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.